Studies on brain tissue recovered from schizophrenia patients provide evidence of molecular alterations in soma-targeting interneurons resulting in lower expression of GAD67 and higher μ-opioid receptor expression, which leads to deficient synthesis and release of GABA (Curley and Lewis 2012; Lewis et al. 2012). The gene discussed is GAD1; the disease is schizophrenia.